Navigation Links
Samarion(SM) to Demonstrate Unprecedented Fall Prevention Component of Enterprise Quality Improvement System for LTC Facilities at the AAHSA 2008 Annual Meeting & Exposition
Date:9/16/2008

Samarion CEO and CAST Commissioner Mark Rodgers Slated as Featured Panelist

for 'Falls and Technology' Education Session

PHILADELPHIA, Sept. 16 /PRNewswire/ -- Stop Falls Now! That is not just a worthwhile message or future goal that Samarion brings to the AAHSA 2008 Annual Meeting and Exposition, but is now a reality. For the first time, Samarion will present live demonstrations of its unprecedented fall prevention system at this show.

Beyond slogans or theory, LTC providers will be able to see firsthand how the SamarionSolution will equip them to significantly prevent unassisted bed exit falls. Falls represent the No. 1 cause of serious accidental injury and deaths in elder home care and LTC facilities. Unlike any other fall management device or notification system, Samarion's restraint-free fall prevention component provides caregivers with the ability to intervene with residents before harmful falls occur. With the SamarionSolution, residents and their families will have an unparalleled level of safety, security and peace of mind.

"The statistics of nursing home falls is staggering," said Samarion Chief Executive Officer Mark E. Rodgers. "While the statistics are overwhelming, we have to remember that behind the numbers are wonderful seniors who deserve the safety and security that technology can now provide. Although we cannot possibly stop every fall, the value of saving one fall is beyond measure. We look forward to working with compassionate caregivers in reversing the fall trend and dramatically improving the quality of life for the millions of seniors in long term care," continued Rodgers.

The SamarionSolution is reliable, easy-to-use transformational technology providing restraint-free fall prevention; unsafe wandering and elopement prevention; abuse and neglect prevention; staff management and facility monitoring; and a family-and-friends communications system that greatly improves the quality of the lives of nursing home residents and their loved ones.

To experience the SamarionSolution first hand, please visit Samarion Booth #1529. Our team of experts, along with owners and administrators of nursing homes with initial implementations of SamarionSolution, will be on hand to answer questions, demonstrate the system, sign up customers, and schedule installations.

Rodgers, also a CAST Commissioner, will be a featured panelist for the "Falls and Technology" education session, to be held on Sunday, Oct. 12, from 3:30-5:30 p.m.

Samarion, a privately-held corporation dedicated to improving the quality of elder care, was recently recognized as an "Emerging High-Growth Company to Watch."

Samarion CEO Mark Rodgers will be available for interviews during the Oct. 12-15 show by phone or in person at the Pennsylvania Convention Center in Philadelphia, Pa.


'/>"/>
SOURCE Samarion
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industrys Only Enterprise Quality Improvement System
2. Samarion(SM) Announces Formation of Outcome Based Study Team for Industrys Only Enterprise Quality Improvement System
3. David B. Samadi, MD, Demonstrates Robotic Prostate Surgery During Live Webcast, August 13, 2008
4. New CDC Report Demonstrates Urgency for All States and Cities to Become Smokefree
5. CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancer
6. GoAmerica(R) and AT&T to Demonstrate Fast, Effective 10-Digit Interoperability Between Video Relay Providers
7. New Survey Demonstrates Increased Awareness of the Dangers of Meth Use
8. Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors
9. New AMITIZA 8 mcg phase III studies demonstrated overall symptom improvement in adult women
10. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
11. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
(Date:2/22/2017)... NJ (PRWEB) , ... February 22, 2017 , ... ... healthcare communications company, launched a new media platform connecting healthcare technology professionals and ... will be followed by a quarterly publication starting on March 1, announced Michael ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued ... according to the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, ... such as the benefits of corn and grains, value of raw and organic diets, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... so many different solutions on the market, it is easy to start feeling ... Premier Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Bioness, Inc., ... therapies, today announced the first series of successful StimRouter ... at Radboud University Medical Center (Nijmegen, Netherlands ... ( Cork, Ireland ), and Kliniek Park ... the successful launch continuing, Bioness plans to further support ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: